Precision for Medicine secures $150M

Precision for Medicine Inc. (Chevy Chase, Md.) secured $150 million in equity in an undisclosed venture round co-led by Oak Investment Partners and J.H. Whitney and Co. The company's co-founders, Ethan Leder and Mark Clein, also participated. Precision for Medicine declined to say how much of the round it has received. The company provides development and commercialization services, infrastructure and technologies to companies developing personalized medicines. In January, Vicki Seyfert-Margolis, formerly director of FDA's Office of Regulatory Science and Innovation, joined the company as chief science and strategy officer. ...